>Year 2005, Issue 4
Vásquez CS, Alcántara MF, Gracida MN, Corona CF, Palomeque LA, Ramírez VJ, Basurto KE
Efficacy of a single cephalothin (2 g iv) dose as prophylactic antibiotic for inguinal mesh repair
Cir Gen 2005; 27 (4)
PDF: 4. Kb.
Objective:To assess the usefulness of administering a single cephalothin dose (2 g, IV) as prophylactic antibiotic in preventing infection at the operation site when performing an open inguinal repair with prosthetic material (polypropylene mesh).
Setting:Third level health care hospital.
Design:Experimental, prospective, longitudinal, comparative, randomized and double-blind study.
Statistical analysis:Percentages (qualitative variables) compared by means of Chi square, α = 0.05.
Results:Sampling was cut at 160 patients (with antibiotic n = 68 and without n = 92), infection at the superficial surgical site presented globally in two (1.25%) patients; both from the non-antibiotic group (2.17%) without statistical significance (p = 1.49). Neither group presented deep infection at the surgical site.
Conclusion:Cephalothin administration (2 g, IV) as prophylactic antibiotic to prevent infection of the surgical wound, when performing open inguinal repair with prosthetic material (mesh), has not shown any benefits yet.
||Prophylactic antibiotic, inguinal hernia, infection of the surgical site.
Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, et al. National Nosocomial Infections Surveillance System (NNIS): description of surveillance methods. Am J Infect Control 1991; 19: 19-35.
National Center for Health Statistics. National Hospital Discharge Survey: Detailed Diagnoses and Procedures 1994. Series 13, No. 127. http://www.cdc.gov/nchs/data/series/sr_13/sr13_127.pdf
Cruse PJ. Wound Infection Surveillance. Rev Infect Dis 1981; 3: 734-7.
Cruse PJ, Foord R. The epidemiology of wound infection: a 10 year prospective study of 62,939 wounds. Surg Clin North Am 1980; 6: 27-40.
Martone WJ, Jarvis WR Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections In: Bennett JV, Braccmann PS, eds. Hospital infections. 3rd ed. Boston, little brown ad Co. 1992: 577-96.
Boyce JM, Potter-Bynoe G, Dziobeck L. Hospital Reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990; 11: 89-93.
Poulsen KB, Bremmelgaard A, Sorensen AI, Raaheve D, Petersen JV. Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol Infect 1994; 113: 283-95.
Vegas AA, Jodra VM, Garcia ML. Nosocomial infection in surgery wards: A controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993; 9: 504-10.
Albers BA, Patka P, Haarman HJ, Kostense PJ. Cost effectiveness of preventive antibiotic administration for lowering risk of infection by 0.25%. Unfallchirurg 1994; 97: 625-8.
Platell C, Hall J. What is the role of mechanical bowel preparation in patients undergoing colorectal surgery? Dis Colon Rectum 1998; 41: 875-82: discussion 882-3.
Clarke JS, Condon RE, Bartlett JG, Gorbach SL, Nichols RL, Ochi S. Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg 1977; 186: 251-9.
Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomized trial. Lancet 1981; 1(8224): 795-6.
Kaiser AB, Petracek MR, Lea JW 4th, Kernodle DS, Roach AC, Alford WC Jr, et al. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1,030 patients. Ann Surg 1987; 206: 791-7.
Sanchez–Manuel FJ, Seco-Gil, JL. Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev 2004; (4): CD003769.
Schumpelick V, Treuner KH, Arlt G. Inguinal hernia repair in adults. Lancet 1994; 344(8919): 375-9.
Medina M, Sillero M, Gallego GM, et al. Risk factors of surgical wound infection in patients undergoing herniorrhaphy. Eur J Surg 1997; 163: 191-8.
Gilbert AI, Felton LL. Infection in inguinal hernia repair considering Biomaterials and antibiotics. Surg Gynecol Obstet 1993; 177: 126-30.
Yerdel MA, Akin EB, Dolalan S, Turkcapar AG, Pehlivan M, Gecim IE, et al. Effect of single-dose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh: the randomized, double-blind, prospective trial. Ann Surg 2001; 233: 26-33.
Platt R, Zaleznik DF, Hopkins CC, Dellinger EP, Karchmer AW, Bryan CS, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med 1990; 322: 153-60.
Glassow F. Is postoperative wound infection following simple inguinal herniorrhaphy a predisposing cause of recurrent hernia? Can Med Assoc J 1964; 91: 870-1.
Mann DV, Prout J, Havranek E, Gould S, Darzi A. Late-onset deep prosthetic infection following mesh repair of inguinal hernia. Am J Surg 1998; 176(1): 12-4.
Zollinger RM Jr. Classification systems for groin hernias. Surg Clin North Am 2003; 83: 1053-63.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250-78; quiz 279-80.
World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925-6.
The Nuremberg Code. JAMA 1996; 276: 1691.
>Year 2005, Issue 4